CTLA4 and neoplasm: Anti-CTLA4 treated mice had a trend towards increase in tumor infiltrating CD8 + T cells compared to control mice, and the combination of propranolol and anti-CTLA4 led to a further increase in the number of tumor infiltrating CD8 + T cells (Fig. 7A, B).